ORIX Life Launches Yen Can, a Yen-Denominated Whole Life Insurance Featuring Affordable Premiums and High Savings Potential

TOKYO, Japan – October 8, 2025 – ORIX Life Insurance Corporation (“ORIX Life”) announced today that it will launch Yen Can, a yen-denominated whole life insurance, on December 2, 2025. In addition, the premium rates for the currently available yen-denominated whole life insurance RISE will be revised on the same day to lower the premiums.^*1

Yen Can is a yen-denominated whole life insurance product^*2 that provides lifelong coverage for death or severe disability, along with a savings feature. By curbing a portion of the coverage^*3 and surrender value during the premium payment period, Yen Can enables customers to secure high savings potential in the future while maintaining affordable premiums.
At the same time, ORIX Life will lower the premium rates for RISE. Without reducing coverage during the premium payment period, RISE will continue to offer lifelong coverage and high savings potential^*4 at even more affordable premiums.

As Japan faces an aging population and declining birthrate, public interest in the social security system continues to grow. In this environment, self-help efforts for building assets and ensuring peace of mind in later life are becoming increasingly important. To meet the needs of customers seeking both death insurance and asset building, ORIX Life has developed and revised yen-denominated whole life insurance products featuring high savings potential. Together with the currently available U.S. dollar-denominated insurance products^*5, ORIX Life now offers a wider range of options to provide products best suited to customers’ diverse values and life plans.

As a life insurance company, ORIX Life has been expanding its lineup of products by enhancing coverage, including death insurance, to meet the needs of its customers. ORIX Life will continue to offer products with coverage and premiums that customers find satisfactory, striving to remain a trusted insurance company chosen with confidence by many customers.

*1 Effective December 2, 2025, sales of medical insurance with death insurance Relief W and Short-Term Term Life Insurance (age group term life insurance) will be discontinued.
*2 This is a flat-rate premium insurance product.
*3 Coverage for death or severe disability caused by reasons other than accidental injury or infectious disease is reduced.
*4 The surrender value during the premium payment period is reduced.
*5 These include U.S. dollar-denominated whole life insurance products Candle, US RISE, and Bright, as well as single-premium whole life insurance Moonshot.
For details regarding the foreign exchange risks and other fees associated with U.S. dollar-denominated insurance products, please refer to this link[282KB] (in Japanese).
For details regarding the risks and fees associated with the single-premium whole life insurance Moonshot, please refer to this link(in Japanese)

Contact Information:
Investor Relations and Sustainability Department
ORIX Corporation
Tel: +81-3-3435-3121

About ORIX Group:
ORIX Group (ORIX Corporation TSE: 8591; NYSE: IX) was established in 1964 and has grown from its roots in leasing in Japan to become a global, diverse, and unique corporate group. Today, it is active around the world in financing and investment, life insurance, banking, asset management, real estate, concession, environment and energy, automobile-related services, industrial/ICT equipment, ships and aircraft. Since expanding outside of Japan in 1971, ORIX Group has grown its business globally and now operates in around 30 countries and regions across the world with approximately 34,000 people. ORIX Group unites globally around its Purpose: “Finding Paths. Making Impact.” combining diverse expertise and innovative thinking to help our world develop in a sustainable way.
For more details, please visit our website: https://www.orix.co.jp/grp/en/
(As of March 31, 2025)

Caution Concerning Forward-Looking Statements:
These documents may contain forward-looking statements about expected future events and financial results that involve risks and uncertainties. Such statements are based on our current expectations and are subject to uncertainties and risks that could cause actual results that differ materially from those described in the forward-looking statements. Factors that could cause such a difference include, but are not limited to, those described under “Risk Factors” in the Company’s annual report on Form 20-F filed with the United States Securities and Exchange Commission and under “(4) Risk Factors” of the “1. Summary of Consolidated Financial Results” of the “Consolidated Financial Results April 1, 2024 – March 31, 2025” furnished on Form 6-K.